Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to hospital departments Pediatrics

Hematology Department

Inner Mongolia People's Hospital

The Pediatric Hematology Department was established in January 2008. It currently has 39 formal beds and 2 stem cell transplantation 100-level laminar flow rooms. There are currently 10 doctors, including 1 chief physician, 4 deputy chief physicians, 4 attending physicians and 1 physician. Distribution of academic qualifications: 1 doctoral candidate and 9 master's degree candidates. There are 19 nurses, including 1 chief nurse, 3 deputy chief nurses, 5 supervisor nurses, 6 nurse practitioners, and 4 nurses. Educational qualifications: 1 has a master's degree and 18 have bachelor's degrees. This department has been responsible for the information management, diagnosis and treatment of hemophilia in the Inner Mongolia Autonomous Region since 2009; in 2010, it was designated as a designated department of the designated hospital for the treatment of childhood leukemia by the Health Department of the Inner Mongolia Autonomous Region. Since 2012, he has applied for charity assistance for childhood leukemia from "Shenhua Group" and "Jackie Chan Foundation". Currently, the department specializes in treating various types of anemia, thrombocytopenia or pleocytosis, hemorrhagic diseases such as Henoch-Schonlein purpura, Epstein-Barr virus infection-related diseases, childhood leukemia, lymphoma, histiocytosis, neuroblastoma and various children's solid tumors.In 2011, the "autologous hematopoietic stem cell transplantation" technology was successfully carried out to treat childhood malignant lymphoma and neuroblastoma. In 2012, the "allogeneic bone marrow transplantation" technology for leukemia was carried out, filling the gap in the autonomous region. In 2016, a case of trisomy 21 combined with leukemia and the "allogeneic cord blood hematopoietic stem cell transplantation" technology filled the gap in the autonomous region. Since 2020, several cases of various molecular targeted treatments have been completed, including belintuzumab, emicizumab, belimumab, etc. The department team has successfully applied for 5 scientific research projects, including 2 in nature, and published several papers in domestic and foreign journals.

Sun Yu

Associate Chief Physician

Childhood leukemia, anemia, allergic purpura, thrombocytopenia, aplastic diseases, etc.

View doctor details

Wu Jin

Associate Chief Physician

Diagnosis and treatment of childhood hematological tumors, bone marrow failure diseases, various anemias, and thrombocytopenia diseases.

View doctor details

Mu Dan

Associate Chief Physician

Diagnosis and treatment of various types of leukemia, anemia, thrombocytopenia, purpura and various solid tumors in children.

View doctor details

Geng An Yang

Associate Chief Physician

Diagnosis and treatment of children's hematological diseases and common and frequently-occurring diseases in children. Anemia, purpura diseases, acute and chronic leukemia, coagulation disorders, myeloproliferative diseases, autoimmune hemolysis, thrombocytopenia, etc.

View doctor details

Remove this favorite?